Skip to main content

Studies on Lysosomal Storage Diseases in Cell Culture: Niemann-Pick Disease Type D

  • Conference paper
Lipid Storage Disorders

Part of the book series: NATO ASI Series ((NSSA,volume 150))

  • 110 Accesses

Abstract

The Niemann-Pick group of diseases are characterized by varying degrees of central nervous system involvement, hepatosplenomegaly, foam-cells in the bone marrow, and variably increased amounts of sphingomyelin, cholesterol, glycosphingolipids and bis(monoacylglycero) phosphate in visceral organs (1–6). In some forms of the disease, the primary defect is a deficiency of the lysosomal sphingomyelinase (EC 3.1.4.12 sphingomyelin choline phosphohydrolase) with activity levels less than 10% of normal (2,6,7). In other forms of the disease, sphingomyelin storage is less marked (2,3,5), sphingomyelinase activities are normal or variably reduced (3–7), and abnormalities in cholesterol esterification have been noted in some (8).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. D.S. Fredrickson, Sphingomyelin lipidosis: Niemann-Pick disease,in Metabolic Basis of Inherited Disease, J.B. Stanbury, J.B. Wyngaarden, and D.S. Fredrickson (eds). 2 ed. New York: McGraw-Hill Book Co, p. 586. (1966).

    Google Scholar 

  2. R.O. Brady, Sphingomyelin lipidoses: Niemann-Pick disease, in Metabolic Basis of Inherited Disease, J.B. Stanbury, J.B. Wyngaarden, D.S. Fredrickson, J.L. Goldstein, and M.S. Brown (eds). 5 ed. New York: McGraw-HiLL Book Co, p. 831. (1983).

    Google Scholar 

  3. M.T. Vanier, Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. Biochim Biophys Acta 750:178 (1983).

    PubMed  CAS  Google Scholar 

  4. G.T. Besley and M. Elleder, Enzyme activities and phospholipid storage patterns in brain and spleen samples from Niemann-Pick disease variants: a comparison of neuropathic and non-neuropathic forms. J Inherited Metab Dis 9:59 (1986).

    Article  PubMed  CAS  Google Scholar 

  5. B.G. Rao and M.W. Spence, Niemann-Pick disease type D: lipid analyses and studies on sphingomyelinases. Ann Neurol 1:385 (1977).

    Article  PubMed  CAS  Google Scholar 

  6. T. Levade, R. Salvayre, and L. Douste-Blazy, Sphingomyelinases and Niemann-Pick disease. J Clin Chem Clin Biochem 24:205 (1986).

    PubMed  CAS  Google Scholar 

  7. M.T. Vanier, R. Rousson, I. Garcia, G. Bailloud, M.C. Juge, A. Revol, and P. Louisot, Biochemical studies in Niemann-Pick disease. III. In vitro and in vivo assays of sphingomyelin degradation in cultured skin fibroblasts and amniotic fluid cells for the diagnosis of the various forms of the disease. Clin Genet 27:20 (1985).

    Article  PubMed  CAS  Google Scholar 

  8. H.S. Kruth, M.E. Comly, J.D. Butler, M.T. Vanier, J.K. Fink, D.A. Wenger, S. Patel, and P.G. Pentchev, Type C Niemann-Pick disease. Abnormal metabolism of low density lipoprotein in homozygous and heterozygous fibroblasts. J Biol Chem 261:16769 (1986).

    PubMed  CAS  Google Scholar 

  9. Winsor, E.J., and J.P. Welch, Genetic and demographic aspects of Nova Scotia Niemann-Pick disease (type D). Am J Hum Genet 30:530 (1978).

    PubMed  CAS  Google Scholar 

  10. J.A.R. Tibbies and J.P. Welch, Clinical and genetic data on twelve cases of Type D Niemann-Pick disease (Abstr.). Pediatr Res 6:634 (1972).

    Google Scholar 

  11. M.W. Spence, J.T. Clarke, and H.W. Cook, Pathways of sphingomyelin metabolism in cultured fibroblasts from normal and sphingomyelin lipidosis subjects. J Biol Chem 258:8595 (1983).

    PubMed  CAS  Google Scholar 

  12. A.L. Beaudet and A.A. Manschreck, Metabolism of sphingomyelin by intact cultured fibroblasts: differentiation of Niemann-Pick disease type A and B. Biochem Biophys Res Commun 105:14 (1982).

    Article  PubMed  CAS  Google Scholar 

  13. S.L. Sutrina and W.W. Chen, Lysosomal involvement in cellular turnover of plasma membrane sphingomyelin. Biochim Biophys Acta 793:169 (1984).

    PubMed  CAS  Google Scholar 

  14. J.C. Maziere, C. Maziere, L. Mora, J.D. Routier, and J. Polonovski, In situ degradation of sphingomyelin by cultured normal fibroblasts and fibroblasts from patients with Niemann-Pick disease type A and C. Biochem Biophys Res Commun 108:1101 (1982).

    Article  PubMed  CAS  Google Scholar 

  15. T. Kudoh, M.A. Velkoff, and D.A. Wenger, Uptake and metabolism of radioactively labeled sphingomyelin in cultured skin fibroblasts from controls and patients with Niemann-Pick disease and other lysosomal storage diseases. Biochim Biophys Acta 754:82 (1983).

    PubMed  CAS  Google Scholar 

  16. T. Levade and S. Gatt, Uptake and intracellular degradation of fluorescent sphingomyelin by fibroblasts from normal individuals and a patient with Niemann-Pick disease. Biochim Biophys Acta 918:250 (1987).

    Google Scholar 

  17. B.G. Rao and M.W. Spence, Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0. J Lipid Res 17:506 (1976).

    Google Scholar 

  18. M.W. Spence, S. Beed, and H.W. Cook, Acid and alkaline ceramidases of rat tissues. Biochem Cell Biol 64:400 (1986).

    Article  PubMed  CAS  Google Scholar 

  19. O. Lindberg and L. Ernster, Determination of organic phosphorus compounds by phosphate analysis,in Methods of Biochemical Analysis,D.Glick (eds). New York:Interscience Publishers Inc, p. 1. (1956).

    Google Scholar 

  20. F.B.S. Palmer, Measurement of 32P following colorimetric phosphorus analysis. Anal’ Biochem 31:493 (1969).

    Article  CAS  Google Scholar 

  21. H.W. Moser and W.W. Chen, Ceramidase deficiency:Farber’s 1ipogranulomatosis,in Metabolic Basis of Inherited Disease, J. B. Stanbury, J.B. Wyngaarden, D.S. Fredrickson, J.L. Goldstein, and M.S. Brown (eds). 5 ed. New York:McGraw-Hi11 Book Co, p. 820. (1983).

    Google Scholar 

  22. J.C. Fratantoni, C.W. Hall, and E.F. Neufeld, The defect in Hurler’s and Hunter’s syndromes: faulty degradation of mucopolysaccharide. Proc Nat Acad Sci USA 60:699 (1968).

    Article  PubMed  CAS  Google Scholar 

  23. J.A. Peterson and H. Rubin, The exchange of phospholipids between cultured chick embryo fibroblasts and their growth medium. Exp Cell Res 58:365 (1969).

    Google Scholar 

  24. Y.A. Hannun and R.M. Bell, Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235:670 (1987).

    Article  PubMed  CAS  Google Scholar 

  25. W. Stoffel, Sphingosine metabolism and its link to phospholipid biosynthesis. Mol Cell Biochem 1:147 (1973).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Plenum Press, New York

About this paper

Cite this paper

Spence, M.W., Cook, H.W., Burgess, J.K. (1988). Studies on Lysosomal Storage Diseases in Cell Culture: Niemann-Pick Disease Type D. In: Salvayre, R., Douste-Blazy, L., Gatt, S. (eds) Lipid Storage Disorders. NATO ASI Series, vol 150. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1029-7_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1029-7_24

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8300-3

  • Online ISBN: 978-1-4613-1029-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics